Compare the Efficacy and Safety of Beta-Glucan as Add-On to Statin in Subjects With Hyperlipidemia.

PHASE2CompletedINTERVENTIONAL

Enrollment

263

Participants

Timeline

Start Date

May 31, 2019

Primary Completion Date

August 31, 2021

Study Completion Date

December 31, 2021

Conditions

Hyperlipidemias

Interventions

DRUG

CP105F

Natural Health Product

DRUG

Placebo

tablet manufactured to mimic the CP105F beta-glucan

Trial Locations (1)

Montreal Heart Institute, Montreal

All Listed Sponsors

collaborator

Ceapro Inc.

INDUSTRY

collaborator

The Montreal Health Innovations Coordinating Center (MHICC)

OTHER

lead

Montreal Heart Institute

OTHER

NCT03857256 - Compare the Efficacy and Safety of Beta-Glucan as Add-On to Statin in Subjects With Hyperlipidemia. | Biotech Hunter | Biotech Hunter